Kamel Mohammedi Selected Research

C-Reactive Protein

2/2024

Skin autofluorescence of Advanced Glycation End-products relates to new cardiovascular events in Type 2 Diabetes: a longitudinal observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kamel Mohammedi Research Topics

Disease

36	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2009
14	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2022 - 03/2011
9	Hypertension (High Blood Pressure) 02/2024 - 06/2010
9	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 12/2011
8	Peripheral Arterial Disease 05/2024 - 01/2018
8	Chronic Kidney Failure (Chronic Renal Failure) 05/2024 - 11/2013
8	Vascular Diseases (Vascular Disease) 03/2024 - 01/2016
7	Diabetic Foot 05/2024 - 01/2016
5	Obesity 03/2024 - 04/2015
5	Stroke (Strokes) 11/2022 - 07/2012
4	Ulcer 05/2024 - 01/2016
4	Foot Ulcer 10/2023 - 01/2016
4	Myocardial Infarction 11/2022 - 07/2012
4	Hyperglycemia 01/2021 - 04/2011
4	Kidney Diseases (Kidney Disease) 01/2018 - 01/2014
4	Insulin Resistance 01/2017 - 06/2010
3	Prediabetic State (Prediabetes) 05/2024 - 01/2017
3	Neoplasms (Cancer) 05/2024 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2018
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 01/2018
3	Heart Failure 12/2022 - 12/2018
3	Coronary Disease (Coronary Heart Disease) 12/2018 - 01/2009
3	Albuminuria 01/2018 - 11/2013
3	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 04/2011
2	Pituitary ACTH Hypersecretion 04/2024 - 01/2023
2	Weight Loss (Weight Reduction) 03/2024 - 01/2021
2	Dyslipidemias (Dyslipidemia) 02/2024 - 10/2023
2	Ischemia 01/2023 - 09/2015
2	Body Weight (Weight, Body) 01/2023 - 11/2022
2	Ketosis 01/2020 - 04/2011
2	Proteinuria 10/2019 - 12/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2016 - 06/2010
1	Dementia (Dementias) 05/2024
1	Cushing Syndrome 04/2024
1	Craniopharyngioma (Craniopharyngiomas) 03/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022
1	Inflammation (Inflammations) 12/2022
1	Ischemic Stroke 11/2022
1	Dysbiosis 11/2021
1	Transient Ischemic Attack 01/2021

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2009
8	CreatinineIBA 05/2024 - 07/2012
8	Advanced Glycation End ProductsIBA 02/2024 - 01/2019
6	Gliclazide (Diamicron)IBA 01/2021 - 01/2016
6	perindopril drug combination indapamideIBA 01/2021 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2017
5	Syntex adjuvant formulationIBA 01/2024 - 01/2019
5	Insulin (Novolin)FDA Link 12/2023 - 04/2011
4	Retinaldehyde (Retinal)IBA 05/2024 - 01/2016
4	AlbuminsIBA 12/2022 - 04/2015
4	omega-Chloroacetophenone (Mace)IBA 12/2022 - 01/2017
4	AdrenomedullinIBA 01/2022 - 09/2015
4	Vasopressins (Vasopressin)IBA 01/2018 - 11/2013
4	Advanced Oxidation Protein Products (AOPP)IBA 02/2016 - 01/2014
3	HDL CholesterolIBA 01/2021 - 01/2009
3	LipidsIBA 01/2021 - 01/2020
3	Type I Tumor Necrosis Factor ReceptorsIBA 10/2018 - 03/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 12/2011
3	Superoxide DismutaseIBA 01/2015 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2018
2	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2024 - 01/2023
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2024 - 11/2022
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 09/2016
2	DiureticsIBA 01/2021 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2020
2	CholesterolIBA 01/2021 - 01/2018
2	8-Hydroxy-2'-DeoxyguanosineIBA 01/2020 - 01/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 01/2014
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2018 - 03/2017
2	Vasodilator Agents (Vasodilators)IBA 12/2018 - 09/2015
2	pro-brain natriuretic peptide (1-76)IBA 12/2018 - 03/2017
2	Peptides (Polypeptides)IBA 12/2018 - 09/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 03/2017
2	AdiponectinIBA 12/2017 - 03/2011
2	H-cadherin (T-cadherin)IBA 12/2017 - 12/2017
2	IsoprostanesIBA 02/2016 - 01/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 04/2011
1	Vitamin K FDA Link 05/2024
1	Insulin Glargine (Lantus)FDA Link 05/2024
1	diformyl dapsone (DFD)IBA 05/2024
1	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2024
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024
1	Exenatide (Byetta)FDA Link 03/2024
1	C-Reactive ProteinIBA 02/2024
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2023
1	Leptin ReceptorsIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	semaglutideIBA 01/2023
1	praliciguatIBA 01/2023
1	Soluble Guanylyl CyclaseIBA 01/2023
1	CytokinesIBA 12/2022
1	S100A12 ProteinIBA 12/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2022
1	SodiumIBA 01/2021

Therapy/Procedure

14	Surgical Amputation (Amputations) 03/2024 - 01/2016
4	Therapeutics 05/2024 - 04/2011
2	Bariatric Surgery 01/2022 - 11/2021
2	Orthotic Devices (Orthosis) 01/2020 - 01/2016
2	Light Coagulation 10/2016 - 01/2016
1	Ligation 01/2023